comparemela.com

Latest Breaking News On - Stonepine capital management - Page 1 : comparemela.com

AIGH Capital Management LLC Takes $4.92 Million Position in Delcath Systems, Inc. (NASDAQ:DCTH)

AIGH Capital Management LLC bought a new position in shares of Delcath Systems, Inc. (NASDAQ:DCTH – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 1,182,198 shares of the company’s stock, valued at approximately $4,918,000. Delcath Systems accounts for 2.0% of AIGH Capital […]

United-states
Gil-aharon
Armistice-capital
Aigh-capital-management
Delcath-systems-inc
Stonepine-capital-management
Worth-venture-partners
Delcath-systems-company-profile
Wealthplan-investment-management
Nasdaq
Capital-management
Delcath-systems

Evolus' (EOLS) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. EOLS has been the subject of a number of other research reports. Barclays upgraded Evolus from an equal weight rating to an […]

United-states
Canada
David-moatazedi
Sandra-beaver
Perceptive-advisors
Lord-abbett
Stonepine-capital-management
Vanguard-group-inc
Securities-exchange-commission
Schroder-investment-management-group
Barclays
Evolus-inc

Q3 2024 EPS Estimates for Alimera Sciences, Inc. (NASDAQ:ALIM) Decreased by Analyst

Alimera Sciences, Inc. (NASDAQ:ALIM – Free Report) – HC Wainwright cut their Q3 2024 earnings per share estimates for shares of Alimera Sciences in a report issued on Thursday, May 16th. HC Wainwright analyst Y. Chen now anticipates that the biopharmaceutical company will earn ($0.01) per share for the quarter, down from their prior forecast […]

United-states
Alimera-sciences
Stonepine-capital-management
Hedge-funds-weigh-in-on-alimera-sciences
News-ratings-for-alimera-sciences-daily
Nasdaq
Maxim-group
Worth-venture-partners
Alimera-sciences-stock-performance
Vanguard-group-inc
Capital-management

HC Wainwright Raises IO Biotech (NASDAQ:IOBT) Price Target to $12.00

IO Biotech (NASDAQ:IOBT – Free Report) had its price objective increased by HC Wainwright from $8.00 to $12.00 in a research report released on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for IO Biotech’s Q2 2024 earnings at ($0.31) EPS, Q3 2024 earnings at […]

Stonepine-capital-management
Armistice-capital
Io-biotech-inc
Health-sciences
Holdingsas-novo
Vivo-capital
Free-report
Get-free-report
Capital-management

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Update

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Update
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
Capital-management
Stonepine-capital-management
Assertio-holdings-inc
Assertio-company-profile
Nasdaq
Armistice-capital
Thompson-siegel-walmsley
Russell-investments-group-ltd
Assertio-holdings
Get-free-report

vimarsana © 2020. All Rights Reserved.